Sign in Subscribe

BeatsAll Hormonal Fertility Maternal Cardio Diagnostics Mental health Longevity Care infra

Beat

Cardio

Cardiometabolic health, GLP-1 companion services, and the female-specific risk biology long missing from cardiac care.

10

Signals

15

Companies

2

Research

2

Events

1

Market maps

1

Beat leads

Capital flow

1 rounds tracked

Veera Health (India's largest online PCOS clinic) crosses $9M+ total raised

Research pulse

3 new studies

Calibrate's 4th annual results report: members achieve 19% avg weight loss over 3 years via GLP-1 + ILI

Policy & regulatory

2 updates

AHA Circulation 2025 Go Red issue calls for mandatory sex-disaggregated cardiovascular data

Latest

Signals in Cardio

Ecosystem Shift · Apr 29
WeightWatchers integrates Zepbound vials via LillyDirect pharmacy for member access
The Index Editorial
Ecosystem Shift ↗
Policy · Feb 1
AHA Circulation 2025 Go Red issue calls for mandatory sex-disaggregated cardiovascular data
The Index Editorial
Policy ↗
Research · Jan 15
Calibrate's 4th annual results report: members achieve 19% avg weight loss over 3 years via GLP-1 + ILI
The Index Editorial
Research ↗
Policy · Dec 20
FDA approves Zepbound (tirzepatide) as first drug for obstructive sleep apnea in adults with obesity
The Index Editorial
Policy ↗
Product Launch · Sep 12
Noom launches GLP-1Rx at $149/month with industry-first 'Taper-Off Guarantee'
The Index Editorial
Product Launch ↗
Research · Aug 30
SELECT trial sex subgroup in JACC: semaglutide reduces MACE in both sexes; women face higher baseline risk
The Index Editorial
Research ↗

Directory

Top organizations in Cardio

Function (GLP-1)

GLP-1 recovery, nutrition, and muscle preservation companion services.

Ro

Telehealth platform; GLP-1 prescribing with bundled coaching and adherence tools.

Calibrate

Specialized obesity-medicine clinic combining GLP-1 prescribing with behavioral coaching.

Noom

Behavioral weight-loss app with GLP-1 program (Noom Med) integration.

WeightWatchers

Public digital weight-management program; acquired Sequence to add GLP-1 prescribing.

Huel

Complete nutrition meal replacement; high-protein SKUs positioned for GLP-1 users.

Maps

Market maps · Cardio

CardioEmerging stack

GLP-1 Companion Ecosystem

The recovery, nutrition, behavioral, and clinical infrastructure forming around GLP-1 use.

Research

Recent analysis · Cardio

Semaglutide in obesity-related HFpEF: sex-stratified efficacy

JACC pooled STEP-HFpEF analysis (n=1,145; 49.7% women): semaglutide produces greater weight loss in women (-9.6%) than men (-7.2%); symptom gains equal.

The Index Editorial·Jun 26, 2024

Semaglutide CV outcomes by sex in SELECT (n=17,604)

JACC prespecified sex-stratified analysis: semaglutide 2.4mg consistently reduces MACE in both sexes; women face higher baseline CV risk at equivalent BMI.

The Index Editorial·Aug 30, 2024

Calendar

Events · Cardio

AHA Scientific Sessions 2025

New Orleans, LA

ObesityWeek® 2025

Beat leads

Analysts covering Cardio

The Index Editorial

The Index Editorial team curates and verifies every signal, research item, and ecosystem entry published on the platform. Each piece is sourced to a primary URL — company press release, SEC filing, peer-reviewed journal, or government report — and dated to the original publication. Named analyst bylines will appear as the team grows.

Beat briefing

Get the Cardio briefing weekly.

A focused read on what's moving in cardio — financings, research, regulatory shifts, and ecosystem moves.